Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced that they have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Salix for $158.00…
Source: Valeant Pharmaceuticals agrees to acquire Salix Pharmaceuticals
Monday, February 23, 2015
Valeant Pharmaceuticals agrees to acquire Salix Pharmaceuticals
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment